TAB2 Promotes the Stemness and Biological Functions of Cervical Squamous Cell Carcinoma Cells

Cancer stem cells are a key population participating in the promotion of the cervical cancer progression through interacting with cancer cells. Existing studies have preliminary revealed that cervical cancer stem cells contribute to tumor recurrence and chemotherapy resistance. However, the specific...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem cells international 2021, Vol.2021, p.6550388-12, Article 6550388
Hauptverfasser: Zhou, Yijia, Liao, Yuandong, Zhang, Chunyu, Liu, Junxiu, Wang, Wei, Huang, Jiaming, Du, Qiqiao, Liu, Tianyu, Zou, Qiaojian, Huang, Hua, Liu, Pan, Ooi, Shiyin, Chen, Run, Xia, Meng, Jiang, Hongye, Xu, Manman, Pan, Yuwen, Yao, Shuzhong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cancer stem cells are a key population participating in the promotion of the cervical cancer progression through interacting with cancer cells. Existing studies have preliminary revealed that cervical cancer stem cells contribute to tumor recurrence and chemotherapy resistance. However, the specific mechanisms involved in regulating cell functions remain largely unknown. Here, we analyzed published data from public databases and our global transcriptome data, thus identifying cancer-related signaling pathways and molecules. According to our findings, upregulated TAB2 was correlated to stem cell-like properties of cervical cancer. Immunohistochemistry staining of TAB2 in normal and cervical cancer tissues was performed. The cell function experiments demonstrated that knockdown of TAB2 reduced the stemness of cervical cancer cells and, importantly, prevented cervical cancer progression. Collectively, the therapeutic scheme targeting TAB2 may provide an option for overcoming tumor relapse and chemoresistance of cervical cancer via obstructing stemness maintenance.
ISSN:1687-966X
1687-9678
1687-9678
DOI:10.1155/2021/6550388